Journal ArticleDOI
Lymphoedema: estimating the size of the problem
Reads0
Chats0
TLDR
The evidence on the magnitude of the problem of lymphoedema in the general population is reviewed and evidence on specific high risk groups within it is provided and the potential for the changing needs in managing this condition is provided.Abstract:
Lymphoedema is a problem frequently encountered by professionals working in palliative care. This article reviews the evidence on the magnitude of the problem of lymphoedema in the general population and provides evidence on specific high risk groups within it. Prevalence is a good indicator of the burden of disease for chronic problems such as lymphoedema, as it indicates the numbers of patients who require care. Incidence is indicative of changes in the causes of lymphoedema and the success of any prevention programmes. Both are important means of assessing the current level of need and the potential for the changing needs in managing this condition. Problems exist in all studies in relation to precise definitions of lymphoedema, inconsistent measures to assess differential diagnosis and poorly defined populations. While there is some evidence of high rates in relation to breast cancer therapy, the total burden of lymphoedema in the general population is largely unknown.read more
Citations
More filters
Journal ArticleDOI
Incidence, Treatment Costs, and Complications of Lymphedema After Breast Cancer Among Women of Working Age: A 2-Year Follow-Up Study
Ya Chen Tina Shih,Ying Xu,Janice N. Cormier,Sharon H. Giordano,Sheila H. Ridner,Thomas A. Buchholz,George H. Perkins,Linda S. Elting +7 more
TL;DR: Although the use of claims data may underestimate the true incidence of lymphedema, women with BCRL had a greater risk of infections and incurred higher medical costs.
Journal ArticleDOI
Lymphedema After Breast Cancer: Incidence, Risk Factors, and Effect on Upper Body Function
TL;DR: In this paper, the prevalence and incidence of secondary lymphedema between 6 and 18 months after breast cancer treatment, personal, treatment, and behavioral correlates of lymphingema status; and the presence of other upper-body symptoms (UBS) and function (UBF).
Journal ArticleDOI
Estimating the population burden of lymphedema.
TL;DR: It is extremely attractive to contemplate that future approaches will entail formal, prospectively designed studies to objectively quantitate incidence and prevalence statistics for individual categories, as well as for the global lymphedema population.
Journal ArticleDOI
Lymphedema in Breast Cancer Survivors: Incidence, Degree, Time Course, Treatment, and Symptoms
Sandra A. Norman,A. Russell Localio,Sheryl Potashnik,Heather A. Simoes Torpey,Michael J. Kallan,Anita L. Weber,Linda T. Miller,Angela DeMichele,Lawrence J. Solin +8 more
TL;DR: Lymphedema after breast cancer is common but mostly mild, and Subtle differences in self-reported hand/arm size and symptoms can be early signs of progressing lymphedEMA.
Journal ArticleDOI
A systematic review of common conservative therapies for arm lymphoedema secondary to breast cancer treatment
TL;DR: It was found that the more intensive and health professional based therapies generally yielded the greater volume reductions, whilst self instigated therapies such as compression garment wear, exercises and limb elevation yielded smaller reductions.
References
More filters
Journal ArticleDOI
Risk of lymphoedema following the treatment of breast cancer.
TL;DR: The incidence of lymphoedema was studied in 200 patients following a variety of treatments for operable breast cancer and arm volume measurement 15 cm above the lateral epicondyle was the most accurate method of assessing differences in size of the operated and normal arm.
Journal ArticleDOI
Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis.
TL;DR: The goal of this study was to identify prevalence of breast carcinoma–related lymphedema, time of onset, and associated predictive factors.
Journal ArticleDOI
Lymphoedema: an underestimated health problem
Christine Moffatt,Peter Franks,Debra C. Doherty,Anne F Williams,C. Badger,Eunice Jeffs,Nick Bosanquet,Peter S. Mortimer +7 more
TL;DR: Chronic oedema arising for reasons other than cancer treatment is much more prevalent than generally perceived, yet resources for treatment are mainly cancer-based, leading to inequalities of care.
Journal ArticleDOI
Chronic Arm Morbidity After Curative Breast Cancer Treatment: Prevalence and Impact on Quality of Life
TL;DR: Treatment for breast cancer is associated with considerable arm morbidity, which has a negative impact on QOL, andArm morbidity should be carefully monitored in future studies involving local treatment modalities for Breast cancer.
Journal ArticleDOI
Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy
Alice B. Kornblith,James E. Herndon,Raymond B. Weiss,Chunfeng Zhang,Enid Zuckerman,Sylvia Rosenberg,Magriet Mertz,David K. Payne,Mary Jane Massie,James F. Holland,Patti Wingate,Larry Norton,Jimmie C. Holland +12 more
TL;DR: The long‐term impact of breast carcinoma and its treatment was assessed in 153 breast carcinomas survivors previously treated on a Phase III randomized trial a median of 20 years after entry to CALGB 7581.